Terry Sharrer's bio:

Dr. Sharrer began as Executive Director, Medical Innovation and Transformation Institute, with the Inova Health System (Fairfax, VA) in July 2007. Formerly, he was the Curator of Health Sciences at the National Museum of American History, Smithsonian Institution, where he had worked for thirty-six years.

Terry Sharrer speaks and writes about a range of life science subjects. In 1987, he co-organized an exhibition titled "The Search for Life: Genetic Technology in the 20th Century." This show also was the inaugural exhibition for the DNA Learning Center at Cold Spring Harbor Laboratory in New York. He has done video documentaries on the Human Genome Project, the beginning of gene therapy, and the molecular biology of cancer. He holds a PhD in history from the University of Maryland, has authored some three dozen publications-including A Kind of Fate, Agricultural Change in Virginia, 1861-1920 (about the biological consequences of the Civil War and the beginning of germ theory practices, Iowa State University Press, 2000)-and currently is writing a history of molecular medicine. For outreach work, has served as Chairman of the Board of Directors of the National Foundation for Cancer Research (Bethesda, MD), board member of the Carilion Biomedical Institute (Roanoke, VA), board member, Immune Deficiency Foundation (Towson, MD), and board member, Inova Fairfax Hospital Cancer Advisory Committee (Fairfax, VA).

Currently, his public service includes: board member of the Fund for Inherited Disease Research (Bryn Mawr, PA); and Science Advisor, for the Loudoun County, VA Department of Economic Development, the Clarke County VA Education Foundation, and the Arizona Science Alliance. With his wife Patty, and sons Alex, age 13, and Nicholas, age 17, he lives in Hamilton, Loudoun County, VA.

Disclosure: G. Terry Sharrer, PhD has stock dividends in Merck and Pfizer.

Terry Sharrer's posts:


February 20, 2024 | | Posted in Newsletter

Motile living biobots self-construct from adult human somatic progenitor seed cells
From Tufts University: “Each Anthrobot begins as a single cell, [MORE]

From Sanger to NGS-History of Genetic Sequencing

February 20, 2024 | | Posted in Newsletter

DNA sequencing methods- from Sanger to NGS
“DNA sequencing has come a long way since its inception in the 1970s. A [MORE]

Lipid Nanoparticle Delivery of Anti-Inflammation siRNAs

February 20, 2024 | | Posted in Newsletter

Lipid nanoparticle delivery of anti-inflammation siRNAs
“Here, [from MIT researchers] several lipid nanoparticle (LNP) formulations are examined, and a lead candidate [MORE]

Continuous-Flow Electroporation of Cancer Cells

February 20, 2024 | | Posted in Newsletter

Continuous-flow electroporation of cancer cells
“The proposed continuous-flow electrorotation (cROT) device can induce electrorotation (ROT) with vertical rotation using two sets [MORE]

Lipids in T2 Diabetes

February 20, 2024 | | Posted in Newsletter

Researchers show how lipids and diabetes are closely linked
“Researchers at the University of Geneva (UNIGE) have made two major discoveries. [MORE]

Subcutaneous Implant Reverses T1 Diabetes

February 20, 2024 | | Posted in Newsletter

Under-skin implant reverses type 1 diabetes without anti-rejection drugs
“Here we [an international collaboration] show that the induction of neovascularization via [MORE]

3D Printing of Self-Heating Microfluidic Devices

February 20, 2024 | | Posted in Newsletter

Scientists 3D print self-heating microfluidic devices
“. . . .  many microfluidic applications require chemical reactions that must be performed at [MORE]

Guiding Artificial Microvesicles in the Brain

February 13, 2024 | | Posted in Newsletter

Riding sound waves in the brain
“Researchers at ETH Zurich, the University of Zurich and the University Hospital Zurich have now [MORE]

Gene Therapy for Arrhythmogenic Cardiomyopathy

February 13, 2024 | | Posted in Newsletter

Therapeutic efficacy of AAV-mediated restoration of PKP2 in arrhythmogenic cardiomyopathy
“Arrhythmogenic cardiomyopathy is a severe cardiac disorder characterized by lethal arrhythmias [MORE]

Promoting Liver Regeneration

February 13, 2024 | | Posted in Newsletter

Promoting liver regeneration
“[Researchers at Boston University] propose vascular-endothelial-growth-factor A (VEGFA) as a therapeutic means to accelerate biliary epithelial-cell (BEC)-to-hepatocyte conversion. [MORE]

Frameshifting with mRNA Therapeutics

February 13, 2024 | | Posted in Newsletter

N1-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting
“Here we [MRC researchers at the University of Cambridge] demonstrate that incorporation of N1-methylpseudouridine [MORE]

3D Printing within the Body

February 13, 2024 | | Posted in Newsletter

“A new 3D printing technique that uses ultrasound and “sono-ink” could one day be used to build bones, blood vessels, [MORE]


February 13, 2024 | | Posted in Newsletter

Resolvin D2–G-protein coupled receptor 18 enhances bone marrow function and limits steatosis and hepatic collagen accumulation in aging
“Aging is associated [MORE]

Spousal Concordance of Hypertension

February 13, 2024 | | Posted in Newsletter

High blood pressure shared between partners in heterosexual couples multinational research reveals link
“[Researchers at Emory University and the University of [MORE]